57 NMPA Guidelines Released in a One Day: Is Your China Registration Strategy Still Current?
NMPA published 57 medical devices final guidelines on July 21, 2026. They are aimed to facilitate manufacturers with clarity in type testing, non-clinical and clinical evaluation and regulatory. . .
NMPA published 57 medical devices final guidelines on July 21, 2026. They are aimed to facilitate manufacturers with clarity in type testing, non-clinical and clinical evaluation and regulatory submission. Impacts from the Guidelines UpdatesFor many manufacturers, these updates may trigger the need for a regulatory gap assessment to determine whether additional actions are required, such as:Updated or supplemental type testingRevisions to Product Technical Requirements (PTRs)Additional nonclinical or clinical evaluation dataSoftware, algorithm, cybersecurity, and interoperability documentation updatesBiocompatibility and material assessmentsLabeling revisions and registration dossier updatesWithnew China GMPeffective November 1, 2026, keeping up to date with your regulations and product requirements are essential. A practical assessment should assess the impact:Whether existing type-testing reports cover the latest technical expectations. Whether product technical requirements and labeling need to be updated. Whether additional nonclinical or clinical evidence is necessary. Whether software, cybersecurity, algorithms, digital workflows, or interoperability introduce new review considerations. Whether changes should be addressed before the next renewal or modification submission. China Med Device, LLC has test engineers at NMPA testing centers, and seasoned clinical and regulatory staff to help you shorten your renewal or new approval time. info@ChinaMedDevice. comDevices by IndicationsThe following 57 medical devices are categorized into FDA assigned indications. AnesthesiologyLow-temperature Analgesia DeviceAnesthesia Reservoir BagAnesthesia LaryngoscopeSingle-use Medical Laryngeal MaskSingle-use Suction CatheterCardiovascularMagnetocardiograph Signal Acquisition DeviceTelemetry Monitoring SystemPulse OximeterChemistryLactic Acid Assay Reagent, Carbon Dioxide Assay ReagentN-acetyl-β-D-glucosaminidase Detection ReagentAdenosine Deaminase Assay ReagentAlanine Aminotransferase Assay ReagentHomocysteine Detection ReagentInsulin Assay ReagentC-peptide Assay ReagentDentalDental Implant Planning SoftwareCustomized Orthodontic ApplianceDental Implant GuideTemporary Crown/BridgeGlass Ceramic Blocks for All-ceramic DenturesDental HandpieceZirconia Blocks for All-ceramic DenturesCustomized DentureGastroenterology and UrologyEndoscopic CuretteInsufflatorElectric Gastric Lavage MachineStaplerSingle-use Sterile Urinary CatheterNasogastric Feeding TubeGeneral and Plastic SurgerySurgical Dissector, Hemostatic BandageMedical DressingSurgical Gauze DressingGeneral HospitalVertical Steam SterilizerMedical Molecular Sieve Oxygen GeneratorTraditional Chinese Medicine Tongue Diagnosis InstrumentSurgical MicroscopeElectric Hospital BedElectric Operating TableMedical Electronic ThermometerAnti-decubitus (Pressure Ulcer) Air MattressHematologyPlatelet AnalyzerD-dimer Detection ReagentObstetrical and GynecologicalNeonatal Oxygen Hood, Single-use Umbilical Cord ScissorsElectronic ColposcopeUmbilical Cord DressingOphthalmicSterile Single-use Ophthalmic Non-active Surgical InstrumentsTonometerOrthopedicSurgical Power DeviceOrthopedic External FixatorBone Cement Cannula AssemblyPhysical MedicineMedical Temperature ControllerToxicologyCarbamazepine Assay ReagentDigoxin Detection ReagentValproic Acid Assay ReagentFive Devices that Manufacturers Should Pay Close AttentionAmong the 57 medical devices, many products are worthy of close regulatory monitoring by overseas manufacturers due to their large market size, high technical barriers, or strong import dependence. The following five products are particularly critical, as the issuance or revision of their registration review guidance principles will directly affect multinational companies’ business operations in China. Magnetocardiograph Signal Acquisition DeviceThe MCG market is highly specialized, dominated byCardioMag Imaging andTristan Technologies, with SQUID-based technology. NMPA’s new guideline establishes China’s first regulatory framework for this next-gen cardiac tool. Manufacturers must review shielding, algorithms, and clinical protocols. Non-compliance risks delayed entry or renewal failures in China’s growing cardiology sector. Telemetry Monitoring SystemLed byGE,Philips, andNihon Kohden, these systems involve complex wireless data transmission. China’s new guideline tightens RF, EMC, and cybersecurity requirements. As China is a top market, overseas firms must verify interoperability and data integrity to meet local standards without disrupting clinical workflows. Pulse OximeterWidely used with leaders likeMasimoandMedtronic. The 2026 revision sharpens accuracy demands, especially for low perfusion and motion artifacts, plus home-use expansion. Manufacturers must confirm their proprietary algorithms (e. g. , Masimo SET®) meet new benchmarks and update labeling. Non-compliance could erode trust or trigger product withdrawal in China. Surgical MicroscopeCarl Zeiss,Leica, andOlympuslead this high-value precision segment. The revised guideline now covers fluorescence imaging and 3D digital features beyond traditional optics. Overseas brands must re-assess resolution, stability, and software functions. Given premium pricing and long replacement cycles, failing to comply would jeopardize market access and reputation for surgical excellence. Customized DentureThough locally produced, materials and CAD/CAM systems come from global suppliers likeDentsply SironaandIvoclar Vivadent. The 2026 revision imposes stricter biocompatibility and digital workflow requirements. Overseas material providers must ensure their products meet new benchmarks, as any non-compliance will delay approvals for their Chinese customers, harming sales in the world’s largest dental market.